Nicole Jones, PA
Physician Assistant · Deptford, NJNPI 1548536246
Payments from drug & device makers
Across 72 payments — averaging $22.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$169
- Dexcom, Inc.$144
- Insulet Corporation$137
- Biosense Webster, Inc.$122
- Bayer$94
- Lilly USA, LLC$89
- plus $833 from 25 others
What the payments were for
- Food & beverage$1,588100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 10 | $169 |
| Dexcom, Inc. | 4 | $144 |
| Insulet Corporation | 3 | $137 |
| Biosense Webster, Inc. | 1 | $122 |
| Bayer | 4 | $94 |
| Lilly USA, LLC | 6 | $89 |
| Xeris Pharmaceuticals, Inc. | 4 | $86 |
| Amneal Pharmaceuticals LLC | 4 | $85 |
| Ascendis Pharma Endocrinology Inc | 4 | $75 |
| Tandem Diabetes Care, Inc. | 2 | $60 |
| Corcept Therapeutics | 3 | $59 |
| Madrigal Pharmaceuticals | 2 | $54 |
| Amgen | 3 | $54 |
| Radius Health, Inc. | 2 | $42 |
| Sequel Med Tech, LLC | 2 | $42 |
| IBSA Pharma Inc. | 2 | $37 |
| Vertex | 2 | $35 |
| Tolmar, Inc. | 1 | $18 |
| Mannkind Corporation | 1 | $17 |
| Heron Therapeutics, Inc. | 1 | $17 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $17 |
| RGH Enterprises LLC | 1 | $15 |
| Medtronic | 1 | $15 |
| AbbVie | 1 | $14 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $14 |
| Ascensia Diabetes Care US Inc. | 1 | $14 |
| Antares Pharma, Inc. | 1 | $14 |
| Boehringer Ingelheim | 1 | $14 |
| Impulse Dynamics (USA) Inc. | 1 | $12 |
| GSK | 1 | $12 |
| Astellas Pharma US Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$122
How this compares
$1,588 in reported general payments places this provider in the 80th percentile of 2,726 physician assistant providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 84 | $169,272 |
| MounjaroTirzepatide | 85 | $141,094 |
| JardianceEmpagliflozin | 39 | $61,254 |
| Humalog Kwikpen U-200Insulin Lispro | 13 | $51,718 |
| TrulicityDulaglutide | 30 | $49,936 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 48 | $35,453 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 14 | $33,275 |
| Humalog Kwikpen U-100Insulin Lispro | 57 | $27,444 |
| JanuviaSitagliptin Phosphate | 19 | $25,180 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 105 | $23,599 |
| Novolog FlexpenInsulin Aspart | 37 | $17,774 |
| FarxigaDapagliflozin Propanediol | 11 | $13,740 |
| Tresiba Flextouch U-100Insulin Degludec | 12 | $11,234 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 65 | $7,080 |
| HumalogInsulin Lispro | 12 | $4,573 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity, Humalog | $89 | $195,603127 claims |
| Novo NordiskOzempic | $169 | $169,27284 claims |
| Boehringer IngelheimJardiance | $14 | $61,25439 claims |
| AbbVieSynthroid | $14 | $3,99246 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $85 | $3,645306 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,726 physician assistant providers in New Jersey.
Other physician assistant in Deptford
- Alexa HetzelEast Windsor$750K
- Nicole Schmid DavisHamilton$148K
- Todd NewmanHoboken$73K
- Patrick McGinnShrewsbury$72K
- Tatiana Dell'aquilaNutley$43K
- Nicole ColucciRiverdale$36K
- Salvatore SciurbaMiddletown$25K
- Jacqueline CristiniEdison$22K
- Mark MazakLakewood$21K
- Andrea BarkerPrinceton$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.